Preeclampsia (PE) is a major cause of maternal and perinatal morbidity and mortality. The
only fundamental treatment for PE is the termination of pregnancy. Therefore, not only …

Preeclampsia, a serious complication of pregnancy, involves intricate molecular and cellular
mechanisms. Fetal microchimerism, where fetal cells persist within maternal tissues and in …

In a prospective cohort of subjects who subsequently developed preeclampsia (PE, n= 14)
versus remaining healthy (NORM, n= 12), early gestation circulating extracellular vesicles …

Introduction Preeclampsia (PE) is a severe obstetrical syndrome characterized by new-onset
hypertension and proteinuria and it is often associated with fetal intrauterine growth …

Simple Summary Nc-RNA are microRNA, long-coding RNA, and circulating-RNA. In this
review we report most recent data regarding the role of nc-RNA in airway diseases, with a …

Pre-eclampsia is a placenta-related complication occurring in 2–10% of all pregnancies.
miRNAs are a group of non-coding RNAs regulating gene expression. There is evidence …

Cardiometabolic diseases, such as type 2 diabetes mellitus (DM) and cardiovascular
disease (CVD), are a great health concern. The strategies aimed to increase awareness and …

Background The widely accepted explanation of preeclampsia (PE) pathogenesis is
insufficient trophoblast invasion and impaired uterine spiral artery remodeling. However, the …

Pre‐eclampsia (PE) is a serious complication in pregnant women characterized by failure of
placental remodeling and is one of the primary causes of changes in the placental structure …

It has been shown that the circular RNA (circRNA) circPTK2 modulates many types of
diseases. However, the possible functions as well as the molecular mechanisms of circPTK2 …